Related Experiment Video
Updated: Jun 21, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Ca2+-Dependent Processes of Innate Immunity in IBD
Francesco Palestra1,2,3, Gina Memoli1,2,3, Annagioia Ventrici1,2,3
1Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.
Inflammatory bowel disease (IBD) involves immune cell dysfunction. This review explores the role of calcium (Ca2+) signaling in IBD pathogenesis, offering new insights into disease mechanisms.
Area of Science:
- Gastroenterology
- Immunology
- Cellular Biology
Background:
- Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is characterized by uncontrolled gastrointestinal inflammation.
- IBD pathogenesis involves dysregulated innate and adaptive immune cell responses.
- Innate immune cells produce pro-inflammatory mediators and reactive oxygen species (ROS), exacerbating intestinal damage and barrier dysfunction.
Purpose of the Study:
- To review and elucidate the critical role of calcium (Ca2+) signaling in the pathogenesis of IBD.
- To explore how Ca2+ dynamics influence immune cell function and inflammatory pathways in the gut.
Main Methods:
- Literature review focusing on cellular and molecular mechanisms.
- Analysis of existing research on immune cell signaling in IBD.
- Synthesis of data on Ca2+ channels, transporters, and their targets in the context of gut inflammation.
Main Results:
- Ca2+ signaling is integral to various immune cell functions, including activation, proliferation, and mediator release.
- Aberrant Ca2+ handling in immune cells contributes to the pro-inflammatory environment seen in IBD.
- Specific Ca2+ pathways are implicated in the abnormal responses of macrophages, T cells, and other immune players in IBD.
Conclusions:
- Calcium signaling represents a significant, yet underexplored, factor in IBD development and progression.
- Targeting Ca2+ pathways may offer novel therapeutic strategies for managing IBD.
- Further research into Ca2+ dysregulation in IBD is warranted to develop effective treatments.
More Related Videos
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...